πŸ‡ΊπŸ‡Έ FDA
Patent

US 7151101

Inhibitors of p38

granted A61PA61P1/04A61P1/18

Quick answer

US patent 7151101 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/04, A61P1/18, A61P11/00, A61P11/06